Symposia: Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Adult, Clinical trials, Epidemiology, Clinical Practice (Health Services and Quality), Lymphomas, Non-Hodgkin lymphoma, Clinical Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Health outcomes research, B Cell lymphoma, T Cell lymphoma, Diseases, Patient-reported outcomes, Indolent lymphoma, Real-world evidence, Treatment Considerations, Biological therapies, Aggressive lymphoma, Lymphoid Malignancies, Registries, Adverse Events, Gene editing, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, Adult, Clinical trials, Epidemiology, Clinical Practice (Health Services and Quality), Lymphomas, Non-Hodgkin lymphoma, Clinical Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Health outcomes research, B Cell lymphoma, T Cell lymphoma, Diseases, Patient-reported outcomes, Indolent lymphoma, Real-world evidence, Treatment Considerations, Biological therapies, Aggressive lymphoma, Lymphoid Malignancies, Registries, Adverse Events, Gene editing, Study Population, Human
Sunday, December 8, 2024: 12:00 PM-1:30 PM
Marriott Grand Ballroom 2-4
(Marriott Marquis San Diego Marina)
Moderators:
Manali K. Kamdar, MD, University of Colorado
and
Gaurav Goyal, MD, Mayo Clinic
Disclosures:
Kamdar: AstraZeneca: Consultancy; Celgene/Bristol-Myers Squibb: Consultancy; Novartis: Research Funding; AbbVie: Consultancy; Beigene: Consultancy; Genentech: Consultancy; SeaGen: Speakers Bureau; Celgene: Other: Data Monitoring Committee; Genentech: Other: Data Monitoring Committee.
12:00 PM
12:15 PM
12:30 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH